These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NK cell receptors and their MHC class I ligands in host response to cytomegalovirus: insights from the mouse genome. Pyzik M; Kielczewska A; Vidal SM Semin Immunol; 2008 Dec; 20(6):331-42. PubMed ID: 18948016 [TBL] [Abstract][Full Text] [Related]
4. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. López-Botet M; Angulo A; Gumá M Tissue Antigens; 2004 Mar; 63(3):195-203. PubMed ID: 14989708 [TBL] [Abstract][Full Text] [Related]
5. Cellular ligands of activating NK receptors. Bottino C; Castriconi R; Moretta L; Moretta A Trends Immunol; 2005 Apr; 26(4):221-6. PubMed ID: 15797513 [TBL] [Abstract][Full Text] [Related]
7. NK cells in HIV infection: paradigm for protection or targets for ambush. Fauci AS; Mavilio D; Kottilil S Nat Rev Immunol; 2005 Nov; 5(11):835-43. PubMed ID: 16239902 [TBL] [Abstract][Full Text] [Related]
10. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity? Zhang C; Zhang J; Wei H; Tian Z Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316 [TBL] [Abstract][Full Text] [Related]
11. Different checkpoints in human NK-cell activation. Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A Trends Immunol; 2004 Dec; 25(12):670-6. PubMed ID: 15530838 [TBL] [Abstract][Full Text] [Related]
12. How do natural killer cells find self to achieve tolerance? Yokoyama WM; Kim S Immunity; 2006 Mar; 24(3):249-57. PubMed ID: 16546094 [TBL] [Abstract][Full Text] [Related]
13. The dynamics of natural killer cell tolerance. Johansson MH; Höglund P Semin Cancer Biol; 2006 Oct; 16(5):393-403. PubMed ID: 16935000 [TBL] [Abstract][Full Text] [Related]
14. Human natural killer cells: Molecular mechanisms controlling NK cell activation and tumor cell lysis. Moretta L; Bottino C; Pende D; Vitale M; Mingari MC; Moretta A Immunol Lett; 2005 Aug; 100(1):7-13. PubMed ID: 16109445 [TBL] [Abstract][Full Text] [Related]
16. NK cell receptors as tools in cancer immunotherapy. Sentman CL; Barber MA; Barber A; Zhang T Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660 [TBL] [Abstract][Full Text] [Related]
17. Specific recognition of virus-infected cells by paired NK receptors. Arase H; Lanier LL Rev Med Virol; 2004; 14(2):83-93. PubMed ID: 15027001 [TBL] [Abstract][Full Text] [Related]
18. NK cell activating ligands on human malignant cells: molecular and functional defects and potential clinical relevance. Chang CC; Ferrone S Semin Cancer Biol; 2006 Oct; 16(5):383-92. PubMed ID: 16931041 [TBL] [Abstract][Full Text] [Related]
19. [Innate nonspecific antiviral immunity]. Błach-Olszewska Z Postepy Hig Med Dosw; 1999; 53(1):3-21. PubMed ID: 10352544 [TBL] [Abstract][Full Text] [Related]
20. Innate immune recognition and suppression of tumors. Hayakawa Y; Smyth MJ Adv Cancer Res; 2006; 95():293-322. PubMed ID: 16860661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]